Resting Energy Expenditure and Cold-induced Thermogenesis in Patients With Overt Hyperthyroidism

J Clin Endocrinol Metab. 2022 Jan 18;107(2):450-461. doi: 10.1210/clinem/dgab706.

Abstract

Context: Thyroid hormone (TH) is crucial for the adaptation to cold.

Objective: To evaluate the effect of hyperthyroidism on resting energy expenditure (REE), cold-induced thermogenesis (CIT) and changes in body composition and weight.

Methods: This was a prospective cohort study at the endocrine outpatient clinic of a tertiary referral center. Eighteen patients with overt hyperthyroidism were included. We measured REE during hyperthyroidism, after restoring euthyroid TH levels and after 3 months of normal thyroid function. In 14 of the 18 patients, energy expenditure (EE) was measured before and after a mild cold exposure of 2 hours and CIT was the difference between EEcold and EEwarm. Skin temperatures at 8 positions were recorded during the study visits. Body composition was assessed by dual X-ray absorption.

Results: Free thyroxine (fT4) and free triiodothyronine (fT3) decreased significantly over time (fT4, P = .0003; fT3, P = .0001). REE corrected for lean body mass (LBM) decreased from 42 ± 6.7 kcal/24 hour/kg LBM in the hyperthyroid to 33 ± 4.4 kcal/24 hour/kg LBM (-21%, P < .0001 vs hyperthyroid) in the euthyroid state and 3 months later to 33 ± 5.2 kcal/24 hour/kg LBM (-21%, P = .0022 vs hyperthyroid, overall P < .0001). fT4 (P = .0001) and fT3 (P < 0.0001) were predictors of REE. CIT did not change from the hyperthyroid to the euthyroid state (P = .96). Hyperthyroidism led to increased skin temperature at warm ambient conditions but did not alter core body temperature, nor skin temperature after cold exposure. Weight regain and body composition were not influenced by REE and CIT during the hyperthyroid state.

Conclusion: CIT is not increased in patients with overt hyperthyroidism.

Trial registration: ClinicalTrials.gov NCT03379181.

Keywords: brown adipose tissue; cold induced thermogenesis; energy expenditure; hyperthyroidism; thyroid hormone.

Publication types

  • Clinical Trial, Phase IV
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Antagonists / therapeutic use
  • Adult
  • Aged
  • Basal Metabolism / physiology*
  • Body Composition
  • Cold Temperature / adverse effects
  • Female
  • Humans
  • Hyperthyroidism / blood
  • Hyperthyroidism / drug therapy
  • Hyperthyroidism / metabolism*
  • Male
  • Middle Aged
  • Prospective Studies
  • Thermogenesis*
  • Thyroid Function Tests
  • Thyroxine / blood
  • Thyroxine / metabolism*
  • Triiodothyronine / blood
  • Triiodothyronine / metabolism*
  • Young Adult

Substances

  • Adrenergic Antagonists
  • Triiodothyronine
  • Thyroxine

Associated data

  • ClinicalTrials.gov/NCT03379181